Literature DB >> 15921895

Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain.

Azucena Mora1, Jesús E Blanco, Miguel Blanco, M Pilar Alonso, Ghizlane Dhabi, Aurora Echeita, Enrique A González, M Isabel Bernárdez, Jorge Blanco.   

Abstract

A total of 722 Shiga toxin-producing Escherichia coli (STEC) isolates recovered from humans, cattle, ovines and food during the period from 1992 to 1999 in Spain were examined to determine antimicrobial resistance profiles and their association with serotypes, phage types and virulence genes. Fifty-eight (41%) out of 141 STEC O157:H7 strains and 240 (41%) out of 581 non-O157 STEC strains showed resistance to at least one of the 26 antimicrobial agents tested. STEC O157:H7 showed a higher percentage of resistant strains recovered from bovine (53%) and beef meat (57%) than from human (23%) and ovine (20%) sources, whereas the highest prevalence of antimicrobial resistance in non-O157 STEC was found among isolates recovered from beef meat (55%) and human patients (47%). Sulfisoxazole (36%) had the most common antimicrobial resistance, followed by tetracycline (32%), streptomycin (29%), ampicillin (10%), trimethoprim (8%), cotrimoxazole (8%), chloramphenicol (7%), kanamycin (7%), piperacillin (6%), and neomycin (5%). The multiple resistance pattern most often observed was that of streptomycin, sulfisoxazole, and tetracycline. Ten (7%) STEC O157:H7 and 71 (12%) non-O157 strains were resistant to five or more antimicrobial agents. Most strains showing resistance to five or more antimicrobial agents belonged to serotypes O4:H4 (4 strains), O8:H21 (3 strains), O20:H19 (6 strains), O26:H11 (8 strains eae-beta1), O111:H- (3 strains eae-gamma2), O118:H- (2 strains eae-beta1), O118:H16 (5 strains eae-beta1), O128:H- (2 strains), O145:H8 or O145:H- (2 strains eae-gamma1), O157:H7 (10 strains eae-gamma1), O171:H25 (3 strains), O177:H11 (5 strains eae-beta1), ONT:H- (3 strains/1 eae-beta1) and ONT:H21 (2 strains). Interestingly, most of these serotypes, i.e., those indicated in bold) were found among human STEC strains isolated from patients with hemolytic uremic-syndrome (HUS) reported in previous studies. We also detected, among non-O157 strains, an association between a higher level of multiple resistance to antibiotics and the presence of the virulence genes eae and stx(1). Moreover, STEC O157:H7, showed an association between certain phage types, PT21/28 (90%), PT23 (75%), PT34 (75%), and PT2 (54%), with a higher number of resistant strains. We conclude that the high prevalence of antimicrobial resistance detected in our study is a source of concern, and cautious use of antibiotics in animals is highly recommended.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15921895     DOI: 10.1016/j.resmic.2005.03.006

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  46 in total

1.  Gene cluster conferring streptomycin, sulfonamide, and tetracycline resistance in Escherichia coli O157:H7 phage types 23, 45, and 67.

Authors:  K Ziebell; R P Johnson; A M Kropinski; R Reid-Smith; R Ahmed; V P Gannon; M Gilmour; P Boerlin
Journal:  Appl Environ Microbiol       Date:  2011-01-14       Impact factor: 4.792

2.  Assessment of virulence factors characteristic of human Escherichia coli pathotypes and antimicrobial resistance in O157:H7 and non-O157:H7 isolates from livestock in Spain.

Authors:  A Cabal; S Gómez-Barrero; C Porrero; C Bárcena; G López; R Cantón; C Gortázar; L Domínguez; J Álvarez
Journal:  Appl Environ Microbiol       Date:  2013-04-19       Impact factor: 4.792

3.  Use of miniaturized protein arrays for Escherichia coli O serotyping.

Authors:  Muna F Anjum; James D Tucker; Katherine A Sprigings; Martin J Woodward; Ralf Ehricht
Journal:  Clin Vaccine Immunol       Date:  2006-05

4.  Antimicrobial resistance in fecal generic Escherichia coli and Salmonella spp. obtained from Ontario sheep flocks and associations between antimicrobial use and resistance.

Authors:  Lisa Scott; Paula Menzies; Richard J Reid-Smith; Brent P Avery; Scott A McEwen; Catherine S Moon; Olaf Berke
Journal:  Can J Vet Res       Date:  2012-04       Impact factor: 1.310

5.  Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.

Authors:  Glenn Buvens; Pierre Bogaerts; Youri Glupczynski; Sabine Lauwers; Denis Piérard
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

6.  Investigation of plasmid-mediated resistance in E. coli isolated from healthy and diarrheic sheep and goats.

Authors:  I I Shabana; A T Al-Enazi
Journal:  Saudi J Biol Sci       Date:  2020-01-16       Impact factor: 4.219

7.  Incidence and virulence determinants of verocytotoxin-producing Escherichia coli infections in the Brussels-Capital Region, Belgium, in 2008-2010.

Authors:  Glenn Buvens; Yves De Gheldre; Anne Dediste; Anne-Isabelle de Moreau; Georges Mascart; Anne Simon; Daniël Allemeersch; Flemming Scheutz; Sabine Lauwers; Denis Piérard
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

8.  Phenotypic and genotypic characterization of verotoxin-producing Escherichia coli O103:H2 isolates from cattle and humans.

Authors:  Musafiri Karama; Roger P Johnson; Robert Holtslander; Carlton L Gyles
Journal:  J Clin Microbiol       Date:  2008-09-03       Impact factor: 5.948

9.  Genotypic characterization and prevalence of virulence factors among Canadian Escherichia coli O157:H7 strains.

Authors:  Kim Ziebell; Marina Steele; Yongxiang Zhang; Andrew Benson; Eduardo N Taboada; Chad Laing; Scott McEwen; Bruce Ciebin; Roger Johnson; Victor Gannon
Journal:  Appl Environ Microbiol       Date:  2008-05-16       Impact factor: 4.792

10.  Associations between antimicrobial resistance phenotypes, antimicrobial resistance genes, and virulence genes of fecal Escherichia coli isolates from healthy grow-finish pigs.

Authors:  Leigh B Rosengren; Cheryl L Waldner; Richard J Reid-Smith
Journal:  Appl Environ Microbiol       Date:  2009-01-09       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.